As lucrative as NBA contracts can be, the league\u2019s top stars understand that their earning potential does not last forever. With careers typically ending in their mid-30s, players are increasingly focusing on long-term financial security. Despite having a large investment portfolio, Milwaukee Bucks star Giannis Antetokounmpo faced criticism for supporting Kalshi, a controversial prediction-market platform, earlier this year.<\/p>\n
However, the Milwaukee superstar has continued to expand his diverse business ventures. The 31-year-old took to Instagram earlier today to announce his partnership with IM8 Health (also known as IM8). David Beckham co-founded the premium health and nutrition brand with the biotech company Prenetics, which is a NASDAQ-registered entity.<\/p>\n
Advertisement<\/p>\n
\u201cI\u2019ve always said, I don\u2019t just endorse things, I invest in what I believe in,\u201d Giannis Antetokounmpo<\/a> posted on his social media platform after announcing the deal. IM8 markets itself as a science\u2011driven, high\u2011end supplement line. It\u2019s designed to \u2018replace\u2019 multiple traditional pills with one streamlined product, targeting everyday wellness, energy, digestion, and longevity.<\/p>\n IM8\u2019s main flagship product is the Daily Ultimate Essentials. It\u2019s an all\u2011in\u2011one powdered supplement that combines roughly 90\u2013100 clinically dosed ingredients (think vitamins, minerals, probiotics, antioxidants, and compounds like CoQ10 and MSM) into one single drink.<\/p>\n IM8 boasts that it can replace 16 capsules and is NSF Certified for Sport. It\u2019s also third\u2011party tested for purity and label accuracy. The brand leans heavily on Beckham\u2019s global athlete\u2011icon status and hopes to bank on Antetokounmpo\u2019s star status as well. Their scientific advisory board features physicians and researchers from institutions like Mayo Clinic and Cedars\u2011Sinai, which adds further credibility to their approach.<\/p>\n Giannis Antetokounmpo\u2019s Kalshi ventures and other investments<\/p>\n Exploring investments that stretch far beyond the hardwood is now commonplace in the modern-day NBA. From tech startups to real estate portfolios and brand ownership, today\u2019s athletes are thinking like entrepreneurs. They realise that they need to use their platform and capital to build sustainable wealth for life after basketball.<\/p>\n Advertisement<\/p>\n Giannis is no different. But his deal with Kalshi landed him in trouble, both with NBA fans and media critics.<\/p>\n Just one day after the 2026 NBA trade deadline, the \u2018Greek Freak\u2019 announced that he was \u201cjoining Kalshi as a shareholder,\u201d adding, \u201cWe all on Kalshi<\/a> now.\u201d This irked fans, considering this could be seen as a massive conflict of interest. They argued that his equity stake in a site that monetized speculation about his own future blurred the line between player and marketplace.<\/p>\n Reporters and critics also highlighted the NBA\u2019s recent high\u2011profile gambling scandal in 2025 as a reason why the league should be extra cautious about players having economic ties to betting\u2011adjacent platforms. Especially considering Kalshi had already run a market on Giannis\u2019 next team before trade deadline day. It led to $25 million in trading volume and essentially cemented Antetokounpo\u2019s belief in the project.<\/p>\n Advertisement<\/p>\n That being said, Kalshi is not the only off-court business venture that the 2021 NBA Champion is involved in. One of his popular headline-grabbing investments featured the Milwaukee Brewers. Giannis purchased a minority stake in the baseball outfit in 2021.<\/p>\n In November 2024, the 2x NBA MVP launched Build Your Legacy (BYL) Ventures, a family-backed venture capital firm focused on sports, entertainment, media, consumer products, and technology. Giannis first ventured investing world through a partnership with Calamos Investments on a sustainable ETF platform.<\/p>\n